Results 221 to 230 of about 29,969,840 (342)
Discovering Data Quality Problems
Ruojin Zhang, M. Indulska, S. Sadiq
semanticscholar +1 more source
Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski+19 more
wiley +1 more source
Development of Data Quality Indicators for Improving Hospital International Classification of Diseases-Coded Health Data Quality Globally. [PDF]
Otero-Varela L+5 more
europepmc +1 more source
An overview of ground-water quality data in Wisconsin [PDF]
P.A. Kammerer, St Sandstone
openalex +1 more source
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau+9 more
wiley +1 more source
Joint models in big data: simulation-based guidelines for required data quality in longitudinal electronic health records. [PDF]
Hunsdieck B+3 more
europepmc +1 more source
Data Quality Guided Incentive Mechanism Design for Crowdsensing
Dan Peng, Fan Wu, Guihai Chen
semanticscholar +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp+13 more
wiley +1 more source
Historical water-quality data for the Clark Fork (river) and the mouths of selected tributaries, western Montana [PDF]
T.M. Brosten, M.A. Jacobson
openalex +1 more source
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald+18 more
wiley +1 more source